The market has had a rocky first two months of 2014 after last year's astronomical boom, but a few medical device stocks have shaken off the dust to roar to great gains on the year so far. Intuitive Surgical (NASDAQ:ISRG) is perhaps the most surprising stock to soar up the charts in 2014: Intuitive's stock crashed in 2013 over fears of slowing growth and the cost of the company's da Vinci robotic surgery machines, but shares of the innovative health care company have taken off by more than 13% year to date.
Intuitive is not alone. Globus Medical (NYSE:GMED), a spinal implant manufacturer, has taken off for investors in the early going of 2014. The same holds true for NuVasive (NASDAQ:NUVA), one of med tech's brightest stars last year that hasn't lost any of its luster as of late.
But can these surging med tech stocks keep impressing investors as 2014 rolls along? Don't leave it up to guesswork: Find out in the video below, as Motley Fool contributor Dan Carroll tells you all you need to know about what's driven these three surprising stocks higher so far this year -- and whether or not they're in danger of slipping up in the coming months.
Watch out for this stock's unrivaled potential in 2014
As Intuitive Surgical investors who have gained huge rewards in the long term know, opportunities to get wealthy from a single investment don't come around often, but they do exist-and our chief technology officer believes he's found one. In this free report, Jeremy Phillips shares the single company that he believes could transform not only your portfolio, but your entire life. To learn the identity of this stock for free and see why Jeremy is putting more than $100,000 of his own money into it, all you have to do is click here now.
Dan Carroll has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.